These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 1685794)

  • 1. Effects of DN-2327, a new anxiolytic, diazepam and buspirone on exploratory activity of the rat in an elevated plus-maze.
    Wada T; Fukuda N
    Psychopharmacology (Berl); 1991; 104(4):444-50. PubMed ID: 1685794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminative stimulus properties of a new anxiolytic, DN-2327, in rats.
    Wada T; Fukuda N
    Psychopharmacology (Berl); 1993; 110(3):280-6. PubMed ID: 7831420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic profile of a new anxiolytic, DN-2327: effect of Ro15-1788 and interaction with diazepam in rodents.
    Wada T; Fukuda N
    Psychopharmacology (Berl); 1991; 103(3):314-22. PubMed ID: 1676179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a new anxiolytic, DN-2327, on learning and memory in rats.
    Wada T; Fukuda N
    Pharmacol Biochem Behav; 1992 Mar; 41(3):573-9. PubMed ID: 1350101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study on the behavioral and EEG changes induced by diazepam, buspirone and a novel anxioselective anxiolytic, DN-2327, in the cat.
    Hashimoto T; Hamada C; Wada T; Fukuda N
    Neuropsychobiology; 1992; 26(1-2):89-99. PubMed ID: 1361973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of the benzodiazepine receptor antagonist flumazenil on the anxiolytic-like effects of CGP 37849 and ACPC in rats.
    Przegaliński E; Tatarczyńska E; Chojnacka-Wójcik E
    Neuropharmacology; 2000 Jul; 39(10):1858-64. PubMed ID: 10884566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cocaine-induced anxiety: alleviation by diazepam, but not buspirone, dimenhydrinate or diphenhydramine.
    Paine TA; Jackman SL; Olmstead MC
    Behav Pharmacol; 2002 Nov; 13(7):511-23. PubMed ID: 12409990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepam.
    Moser PC; Tricklebank MD; Middlemiss DN; Mir AK; Hibert MF; Fozard JR
    Br J Pharmacol; 1990 Feb; 99(2):343-9. PubMed ID: 1970269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A possible mechanism for the anxiolytic-like effect of gallic acid in the rat elevated plus maze.
    Mansouri MT; Soltani M; Naghizadeh B; Farbood Y; Mashak A; Sarkaki A
    Pharmacol Biochem Behav; 2014 Feb; 117():40-6. PubMed ID: 24345572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic characterization of a novel non-benzodiazepine selective anxiolytic, DN-2327.
    Wada T; Nakajima R; Kurihara E; Narumi S; Masuoka Y; Goto G; Saji Y; Fukuda N
    Jpn J Pharmacol; 1989 Mar; 49(3):337-49. PubMed ID: 2568511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone.
    Griebel G; Perrault G; Sanger DJ
    Psychopharmacology (Berl); 1998 Jul; 138(1):55-66. PubMed ID: 9694527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral effects of diazepam in the murine plus-maze: flumazenil antagonism of enhanced head dipping but not the disinhibition of open-arm avoidance.
    Dalvi A; Rodgers RJ
    Pharmacol Biochem Behav; 1999 Apr; 62(4):727-34. PubMed ID: 10208379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxiolytic profile of girisopam and GYKI 52,322 (EGIS 6775). Comparison with chlordiazepoxide and buspirone.
    Horváth K; Andrási F; Botka P; Hámori T
    Acta Physiol Hung; 1992; 79(2):153-61. PubMed ID: 1363928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anxiolytic effect of berberine on exploratory activity of the mouse in two experimental anxiety models: interaction with drugs acting at 5-HT receptors.
    Peng WH; Wu CR; Chen CS; Chen CF; Leu ZC; Hsieh MT
    Life Sci; 2004 Oct; 75(20):2451-62. PubMed ID: 15350820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of inflammatory nociception on the anxiolytic-like effect of diazepam and buspirone in rats.
    Fernández-Guasti A; Reyes R; Martínez-Mota L; López-Muñoz FJ
    Psychopharmacology (Berl); 2005 Jul; 180(3):399-407. PubMed ID: 15719217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat.
    Pellow S; File SE
    Pharmacol Biochem Behav; 1986 Mar; 24(3):525-9. PubMed ID: 2871560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-anxiety effects of Apocynum venetum L. in the elevated plus maze test.
    Grundmann O; Nakajima J; Seo S; Butterweck V
    J Ethnopharmacol; 2007 Apr; 110(3):406-11. PubMed ID: 17101250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of benzodiazepine receptors located in the dorsal periaqueductal grey of rats in anxiety.
    Russo AS; Guimarães FS; De Aguiar JC; Graeff FG
    Psychopharmacology (Berl); 1993; 110(1-2):198-202. PubMed ID: 7870885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the elevated plus-maze the anxiolytic-like effects of the 5-HT(1A) agonist, 8-OH-DPAT, but not the anxiogenic-like effects of the 5-HT(1A) partial agonist, buspirone, are blocked by the 5-HT1A antagonist, WAY 100635.
    Collinson N; Dawson GR
    Psychopharmacology (Berl); 1997 Jul; 132(1):35-43. PubMed ID: 9272757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacology of VA21B7: an atypical 5-HT3 receptor antagonist with anxiolytic-like properties in animal models.
    Artaiz I; Romero G; Zazpe A; Monge A; Calderó JM; Roca J; Lasheras B; Del Río J
    Psychopharmacology (Berl); 1995 Jan; 117(2):137-48. PubMed ID: 7753959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.